# Imaging Tau in Alzheimer's Disease and Normal Aging

> **NCT02884492** · PHASE2 · TERMINATED · sponsor: **William Charles Kreisl** · enrollment: 17 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** 18F-THK-5351
- **PROCEDURE:** Lumbar Puncture (optional)

## Key facts

- **NCT ID:** NCT02884492
- **Lead sponsor:** William Charles Kreisl
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-07
- **Primary completion:** 2017-06-30
- **Final completion:** 2017-06-30
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** Stopped due to published data regarding THK-5351 non-specificity in Tau imaging
- **Last updated:** 2018-11-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02884492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02884492, "Imaging Tau in Alzheimer's Disease and Normal Aging". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02884492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*